Moreover, since single blockade of PD-1 and Tim-3 has been shown to augment atherosclerotic lesion development in experimental AS[22,23,24], approaches to promote the PD-1 and Tim-3 pathway may represent novel therapeutic strategies to inhibiting atherosclerotic lesion development and preventing cardiovascular disease. Here, PDCD1 is linked to cardiovascular disorder.